1. I. P. Ashmarin, Glyprolines in as Part of Regulator Tripeptides. Neirokhimiya, 24, No. 1, 5-7 (2007).
2. N. A. Andreeva, E. V. Stel’mashuk, N. K. Isaev, R. U. Ostrovskaya, T. A. Gudasheva, and I. V. Viktorov, Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress. Bull. Exp. Biol. Med., 130, No. 10. 969-972 (2000).
3. T. A. Gudasheva, R. U. Ostrovskaya, S. S. Trofimov, M. Yu. Kosoi, F. V. Ienkina, Yu. V. Burov, and A. P. Skodinov, Peptide analogs of Piracetam as ligands of assumed nootropic receptors. Khim.-Farm. Zh., 19, No. 11. 1322-1324 (1985).
4. R. U. Ostrovskaya, Yu. V. Vakhitova, M. Kh. Salimgareeva, R. S. Yamidanov, S. V. Sadovnikov, I. G. Kapitsa, and S. B. Seredenin, On the mechanism of noopept action: decrease in activity of stress-induced kinases and increase in expression of neutrophines. Eksp. Klin. Farmakol., 73, No. 12, 2-5 (2007).
5. K. S. Us, P. M. Klodt, V. S. Kudrin, R. U. Ostrovskaya, K. S. Rayevsky, A. Ya. Sapronova, and M. V. Ugryumov, The effect of the synthetic neuroprotective dipeptide Noopept on glutamate release from rat brain cortex slices. Neurochemical Journal, 1, No. 2, 138-142 (2007).